Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies to create first- and best-in-class antiviral drugs. The company was founded in 2008 and is headquartered in Bothell, WA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
11
Frequently Asked Questions
What is Market Cap of Cocrystal Pharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cocrystal Pharma Inc market cap is $16.3M.
What is the 52-week high for Cocrystal Pharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cocrystal Pharma Inc 52 week high is $3.26 as of September 28, 2025.
What is the 52-week low for Cocrystal Pharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cocrystal Pharma Inc 52 week low is $1.12 as of September 28, 2025.
What is Cocrystal Pharma Inc stock price today?
Cocrystal Pharma Inc stock price today is $1.25.
What was Cocrystal Pharma Inc stock price yesterday?
Cocrystal Pharma Inc stock price yesterday was $1.25.
What is the PE ratio of Cocrystal Pharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cocrystal Pharma Inc’s P/E ratio is -1.01.
What is the Price-to-Book ratio of Cocrystal Pharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cocrystal Pharma Inc P/B ratio is 2.3847.
What is the 50-day moving average of Cocrystal Pharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cocrystal Pharma Inc 50-day moving average is $1.54.